Clinical Trial Update: Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer [Phase 3]

View source ↗

Summary

Phase 3 study comparing Pazopanib to Sunitinib in advanced or metastatic renal cell carcinoma completed with results posted in 2012, focusing on patient prefere…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Pazopanib (Pazopanib)
• Sunitinib (sunitinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Carcinoma, Renal Cell | Phase 3 | Status: COMPLETED | Results posted: 2012-08-23